Stroke Clinical Trial
— RISEOfficial title:
Effectiveness of the RISE Intervention to Reduce and Interrupt Sedentary Behaviour in Community Dwelling Sedentary People After First-ever Stroke
Study aim: To determine the effectiveness of the RISE intervention on reducing sedentary behaviour after discharge from acute hospital care in community dwelling people with a first-ever stroke, who have a sedentary movement behavioural pattern (so called 'sedentary prolongers' and 'sedentary movers') in comparison to usual care, at the end of the intervention period (T1). Who can participate? People aged over 18, who return home after acute care with a first-ever stroke, who are independent in walking with or without a walking aid, will be included in the RISE intervention study. What does the study involve? In this clinical randomized controlled trial, participants with first-ever stroke and a sedentary movement pattern will be included and randomly assigned to either the experimental group who will receive RISE intervention and usual care or the control group who will receive usual care. Primary and secondary outcome will be measured at baseline, post-treatment and six, nine and 12 months post-randomisation.
Status | Recruiting |
Enrollment | 197 |
Est. completion date | October 2025 |
Est. primary completion date | January 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: In order to be eligible to participate in the baseline measurement of the intervention study, a subject must meet all of the following criteria: 1. Aged 18 years or older; 2. All types of first-ever stroke diagnosed in hospital within six months before start of the RISE intervention; 3. Able to walk independently, as defined by a Functional ambulation categories score of at least 3; 4. Independent regarding activities of daily living pre-stroke, as defined by a Barthel Index score of >18; 5. Discharged to the home-setting; 6. Not participating in a physical rehabilitation program lasting = 3 months; 7. Given their written informed consent. Exclusion Criteria: A potential subject will be excluded from participation in this study if: 1. The participant has insufficient knowledge or is cognitively unable to understand the Dutch language of the intervention content; 2. The participant has severe comorbidities that withhold that person from safely reducing and interrupting their sedentary time (e.g. sever pulmonary diseases, hart failure or malignity's) as determined with the Physical Activity Readiness Questionnaire; |
Country | Name | City | State |
---|---|---|---|
Netherlands | Fysio 4 Den Bosch | 's-Hertogenbosch | Noord-Brabant |
Netherlands | Fysiotherapie Beelen | Breukelen | Utrecht |
Netherlands | Meras & Vital Fysiotherapie | Eersel | Noord-Brabant |
Netherlands | PMC Eindhoven | Eindhoven | Noord-Brabant |
Netherlands | Stroomz Prinsejagt | Eindhoven | Noord-Brabant |
Netherlands | Fysiotherapie Zesgehuchten | Geldrop | Noord-Brabant |
Netherlands | Fysiotherapie Rakthof | Helmond | Noord-Brabant |
Netherlands | JVDI De Fysioclub | Helmond | Noord-Brabant |
Netherlands | Fysiotherapie Zorgspectrum Houten eerstelijn | Houten | Utrecht |
Netherlands | Fysiotherapie Groene Biezen | Ijsselstein | Utrecht |
Netherlands | MTCFysio | Mijdrecht | Utrecht |
Netherlands | Vivent | Rosmalen | Noord-Brabant |
Netherlands | Leidsche Rijn Julius Gezondheidscentra | Utrecht | |
Netherlands | Van Hoof, centrum voor therapie en gezondheid | Valkenswaard | Noord-Brabant |
Netherlands | Rembrandt fysiotherapie en revalidatie | Veenendaal | Utrecht |
Netherlands | Fysio Annette de Gooijer | Vlijmen | Noord-Brabant |
Netherlands | Fysio Vught Noord | Vught | Noord-Brabant |
Netherlands | Fysiofit Vught | Vught | Brabant |
Netherlands | Fysio Frankenhof | Wijk bij Duurstede | Utrecht |
Netherlands | Synergy Fysiotherapie | Woerden | Utrecht |
Netherlands | Van Tongeren Fysiotherapeuten | Zeist | Utrecht |
Lead Sponsor | Collaborator |
---|---|
UMC Utrecht |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Patient characteristics | Patient characteristics will be measured with an intake questionnaire ((age, gender, education level, living situation (number of persons in the household), comorbidities, measured with CIRS (50), stroke characteristics (type of stroke, side of stroke, time since stroke) and vascular risk factors (coronary artery disease, AF, diabetes, hypertension, clinical obesity, smoking and alcohol use, hyperlipidemia). | Baseline (T0) | |
Other | Walking speed | Walking speed will be measured with the 5 meter walk test (5MWT) in which the participants is asked to walk 5 meters 3 times. Form the average duration of these three times the walking speed is calculated in meters per second. | Baseline (T0) | |
Other | Cognitive functioning | Cognitive functioning will be assessed using the Montreal Cognitive Assessment (MoCA).
MoCA assesses eight domains of cognitive functioning with small tasks. The scores range from 0-30, a score of <26 indicates impaired cognitive function. |
Baseline (T0) | |
Other | Mental health status | Mental health status will be measured with the Hospital Anxiety and Depression Scale (HADS).
The HADS is a short questionnaire of 14 items with a 4-point Likert scale. A higher score indicates more mental health problems. |
Baseline (T0) - One year post-randomisation (T4) | |
Other | Patients' healthcare utilization and patients' (unpaid) productivity losses | Patients' healthcare utilization and patients' (unpaid) productivity losses will be measured using cost questionnaires.
There will be made use of retrospective 3-month cost questionnaires to avoid recall bias. Healthcare utilization will be valued using Dutch standards costs (56). If these are unavailable, prices reported by professional organizations will be used. will be valued in accordance with the "Dutch Manual of Costing". |
Baseline (T0) - One year post-randomisation (T4) | |
Other | Compliance to the RISE intervention | Compliance to the treatment protocol will be measured with a questionnaire filled out by the physical therapists. Compliance consists of 1) the number of people that completed the intervention (with and without missing sessions); 2) The number of participants that mist one or more of the face to face sessions, the reasons for missing, and the percentage of missed sessions per participant; 3) The amount of sessions the participatory support was present; 4) The average amount of times participants used the RISE eCoaching system per week | Three months post-randomisation (T1) | |
Other | Safety during the RISE intervention and follow-up measurements. | Safety will be objectified by the number of adverse events registered by the researcher during the intervention and/or during the follow-up measure following the registration process. | Baseline (T0) - One year post-randomisation (T4) | |
Other | Health Related Quality of Life | Health Related Quality of Life will be measured with the questionnaire: EuroQol-5D (EQ-5D).
This questionnaire comprises of 5 dimensions i.e., mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Per dimension, patients are asked to indicate their health status on a 5-point Likert scale (1 = no problems; 5 = extreme problems). The health states can be converted into utility units by means of the Dutch rates. Utilities represent quality of life into a single number that ranges from 0 (death) to 1 (full health). Quality Adjusted Life Years (QALY's) can subsequently be calculated by multiplying the patients' utilities by the duration of time they spent in that particular health status. |
Baseline (T0) - One year post-randomisation (T4) | |
Primary | Sedentary behaviour | Amount of sedentary time objectively measured with ActivPAL (activity monitor) | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Fragmentation of sedentary behaviour | The fragmentation index of sedentary behaviour objectively measured with ActivPAL (PAL Technologies Ltd, Glasgow, United Kingdom, activity monitor). | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Sedentary time interruption | The sedentary time interruption (amount of sedentary bouts, average sedentary bout duration, percentage of sedentary time accumulated in bouts over 30 min and 60 min) will be objectively measured with ActivPAL (PAL Technologies Ltd, Glasgow, United Kingdom, activity monitor). | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Amount of light physical activity | Amount of light physical activity objectively measured with ActivPAL (activity monitor) | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Amount of moderate to vigorous physical activity | Amount of moderate to vigorous physical activity objectively measured with ActivPAL (activity monitor) | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Self-management | Self-management measured with questionnaire: Patient Activation Measure (PAM). The Pam 13-Dutch is a reliable 13-item instrument and assesses patient (or consumer) self-reported knowledge, skills and confidence for self-management of one's health or chronic condition. The answering categories per item are 4-point Likert scales, ranging from totally disagree to totally agree and 'non applicable'. A higher score (range 1-100) indicates a higher level of self-management. | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Self-efficacy | Self-efficacy measured with questionnaire: Self-Efficacy Symptom Management Scale (SESx).
This questionnaire consists of 13 items scored on a 10-point scale ranging from 'not confident at all' to 'completely confident'. A higher score indicating higher self-efficacy. |
Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Sedentary behaviour (long term) | Amount of sedentary time objectively measured with ActivPAL | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | End-user satisfaction of the RISE eCoaching system | End-user satisfaction of the RISE eCoaching system will be measured with questionnaire: End-User Computing Satisfaction (EUCS).
The EUCS is a 12-item questionnaire to measure end-use computing satisfaction of the (experimental group) participant and physiotherapists about usage of the RISE eCoaching system. All items are scored with a 5-point Likert scale ('almost never' to 'almost always'). |
Three months post-randomisation (T1) | |
Secondary | Acceptability of the RISE eCoaching system | Acceptability of the RISE eCoaching system will be measured with questionnaire: Post-Study System Usability Questionnaire (PSSUQ).
The PSSUQ is a 19-item instrument that assesses the perceived satisfaction of a user with a system, in this case the RISE eCoaching system. |
Three months post-randomisation (T1) | |
Secondary | Usability of the RISE eCoaching system | Usability of the RISE eCoaching system will be measured with questionnaire: System Usability Scale (SUS).
The SUS is a questionnaire that measures the perceived usability of the m-health part of the intervention by posing 10 statements which the participant can rate on a 5-points Likert scale ('completely agree' to 'completely disagree'). The score ranges from 0-100, with a higher score indicating a higher perceived usability. |
Three months post-randomisation (T1) | |
Secondary | Sleep quality | Sleep quality will be objectively measured with the Emfit QS Sleep tracker (Emfit Ltd, Vaajakoski, Finland; 542 3 70 3 1.4 mm).
Next to the Emfit QS, experienced sleep quality is measured with the Pittsburgh Sleep Quality Index (PSQI). ThePSQI is a 19-item self-reported questionnaire about experienced sleep quality in the past month. |
Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Sleep quantity | Sleep quantity will be objectively measured with the Emfit QS Sleep tracker (Emfit Ltd, Vaajakoski, Finland; 542 3 70 3 1.4 mm) | Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Level of fatigue | Level of fatigue will be measured with questionnaire: Fatigue Severity Scale-7 (FSS-7).
The items are asked about the past few weeks and relate to the perceived severity of fatigue in different daily situations. The FSS-7 measures chronic fatigue in 7 items with a 7-point likert scale (ranging from 'totally disagree' to 'totally agree'). The final score is the mean of the 7 item scores. A final score of =4 indicates that the severity of fatigue has a medium to high impact on daily life. |
Baseline (T0) - One year post-randomisation (T4) | |
Secondary | Physical functioning and participation | Physical functioning and participation will be measured using the Short Physical Performance Battery (SPPB).
The Short Physical Performance Battery (SPPB) is an objective assessment tool for evaluating lower extremity functioning in older persons, which gives insight in someone's walking speed, balance and leg strength. The SPPB consists of a balance test, a gait speed test and a chair stand test, of which each item is score with 1, 2 or 4 points. The maximal total score is 12, in which a higher score indicates better lower extremity functioning. |
Baseline (T0) - Three months post-randomisation (T1) | |
Secondary | Stroke physical impact | Stroke physical impact will be measured with questionnaire: Stroke Impact Scale (SIS).
This questionnaire has 37 questions in 5 domains (strength, hand function, activities daily living /Instrumental activities daily living, mobility and participation/ role and function). In this study, the domain 'activities daily living' is used. These questions are answered on a 5-point Likert scale ranging from 1, negative (e.g. 'no strength at all' or 'extremely difficult'), to 5 (e.g. 'a lot of strength' or 'not difficult at all'). |
Baseline (T0) - One year post-randomisation (T4) | |
Secondary | 24h activity pattern (sedentary behaviour, physical activity and sleep) | Change in sleep quantity, amount of time spent sedentary, amount of time spent in light physical activity and amount of time spent moderate to vigorous physical activity will be combined to report the 24h activity pattern. | Baseline (T0) - One year post-randomisation (T4) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Recruiting |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Active, not recruiting |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT00859885 -
International PFO Consortium
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Recruiting |
NCT05993221 -
Deconstructing Post Stroke Hemiparesis
|